Gland Pharma IPO share allotment: The allotment of shares under the Gland Pharma IPO is going to take place today i.e. on November 17. This IPO will be listed on the stock market on 20 November. This is the largest IPO by a pharma company in the country. It has got a good response from investors. No matter how much subscription the issue has received at the moment, not every bettor gets that share. If you have applied for this then it is important to know whether you got allot for this or not. You can check this very easily, know its way.
2.06 times was subscribed
Gland Pharma’s Rs 6500 crore Initial Public Offer (IPO) received a good response from investors. This issue was subscribed 2.06 times, i.e. 2.06 times bids were received for it. Reserve passersons received 6.4 times bids for institutional buyers. For retail investors, the Reserve Porson subscribed 24 per cent, while the share of Non-Institutional Investments was subscribed 51 per cent. The company had fixed a price of Rs 1490–1500 per share for this IPO.
Option 1: From BSE website
For this, first you have to go to the BSE website.
After that the equity box has to be checked.
Then you have to enter the name of the issue in the dropdown, eg Gland Pharma
After that you have to type your application number in the box.
After that you will have to provide information about your PAN number.
Finally, you have to click on the search button, after which the complete information will be revealed.
Option 2: On the registrar’s website
The registrar for this IPO is Link Intime India, whose website has to be visited.
The website is https://www.linkintime.co.in/IPO/public-issues.html.
Type company name Gland Pharma in the dropdown
After that enter PAN number, application number or depository/client ID in the box
Then enter the captcha and click on the search button.
Note: In both cases, if the allotment of the share is final, then you will get information about your status.
Drug company’s largest IPO
The Rs 6,500 crore IPO of Gland Pharma is the largest IPO brought by any pharmaceutical company. Earlier, Aris Lifesciences raised Rs 1,741 crore from its IPO in 2017. Gland Pharma is originally promoted by Fosun Singapore and Shanghai Fosan Pharma. Gland Pharma manufactures injectable drugs. The company sells its products in 60 countries including India, USA, UK, Australia and Canada.
Financial position of the company
Gland Pharma achieved a revenue of Rs 2,772 crore during the last financial year as compared to Rs 2,129.7 crore in the previous financial year. The company’s profit in the financial year 2019-20 was Rs 772.8 crore as compared to Rs 451.8 crore in the previous financial year.
#Gland #Pharma #IPO #Share #allotted #Check #status #ways